Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure

Journal of Clinical Investigation

Volumn 97, Issue 9, 1996, Pages 2092-2100

  Marrades, Ramon M ^a   Roca, Josep ^a   Campistol, Josep M ^a   Diaz, Orlando ^a   Barberà, Joan A ^a   Torregrosa, Josep V ^a   Masclans, Joan R ^a   Cobos, Albert ^b   Rodriguez Roisin, Robert ^a   Wagner, Peter D ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b Research and Development Department   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

exercise; leg blood flow; muscle O2 conductance; oxygen delivery; oxygen uptake

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; OXYGEN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MUSCLE CAPILLARY; MUSCLE EXERCISE; MUSCLE MITOCHONDRION; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 0008868647     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118646     Document Type: Article

References (33)

1. Winearls, C.G., D.O. Oliver, M.J. Pippard, C. Reid, M.R. Downing, and P.M. Cotes. 1986. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis. Lancet. ii:1175-1178.
2. Eschbach, J.W., J.C. Egrie, M.R. Downing, J.K. Browne, and J.W. Adamson. 1987. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N. Engl. J. Med. 316:73-78.
3. Eschbach, J.W., J. Mladenovic, J.F. Garcia, P.W. Wahl, and J.W. Adamson. 1984. The anemia of chronic renal failure in sheep: response to erythropoietin-rich plasma in vivo. J. Clin. Invest. 74:434-441.
4. Eschbach, J.W., and J.W. Adamson. 1988. Recombinant human erythropoietin: implications for nephrology. Am. J. Kidney Dis. 11:203-209.
5. Canadian Erythropoietin Study Group. 1990. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br. Med. J. 300:573-578.
6. Mayer, G., J. Thum, and H. Graf. 1989. Anaemia and reduced exercise capacity in patients on chronic haemodialysis. Clin. Sci. 76:265-268.
7. Macdougall, I.C., N.P. Lewis, M.J. Saunders, D.L. Cochlin, M.E. Davies, R.D. Hutton, K.A.A. Fox, G.A. Coles, and J.D. Williams. 1990. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. Lancet. 335:489-493.
8. Robertson, H.T., N.R. Haley, M. Guthrie, D. Cardenas, J.W. Eschbach, and J.W. Adamson. 1990. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am. J. Kidney Dis. 15:325-332.
9. Satoh, K., T. Masuda T, Y. Ikeda, S.H. Kurokawa, K. Kamata, R. Kikawada, T. Takamoto, and F. Marumo. 1990. Hemodynamic changes in recombinant erythropoietin therapy in hemodialyzed patients. Hypertension (Dallas). 15:262-266.
10. Metra, M., G. Cannella, G. La Canna, T. Guaini, M. Sandrini, M. Gaggiotti, E. Movilli, and L. Dei Cas. 1991. Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure. Am. J. Cardiol. 68: 1060-1066.
11. Lundin, A.P., M.J.H Akerman, R.M. Chesler, B.G. Delano, N. Goldberg, R.A. Stein, and E.A. Friedman. 1991. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin, Nephron. 58:315-319.
12. McMahon, L.P., J.A. Johns, A. McKenzie, M. Austin, R. Fowler, and J.K. Dawborn. 1992. Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietin. Nephrol. Dial. Transplant. 7:1199-1206.
13. Davenport, A. 1993. The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hospital hemodialysis. Am. J. Kidney Dis. 22:685-690.
14. Painter, P., and G.E. Moore. 1994. The impact of recombinant human erythropoietin on exercise capacity in hemodialysis patients. Adv. Renal Replacement Therapy. 1(1):55-65.
15. 2max. J. Appl. Physiol. 73:1067-1076.
16. 2max. Respir. Physiol. 93:221-237.
17. Roca, J., J. Sanchis, A. Agustí-Vidal, F. Segarra, D. Navajas, R. Rodriguez-Roisin, P. Casan, and S. Sans. 1986. Spirometric reference values from a Mediterranean population. Bull. Eur. Physiopath. Respir. 22:217-224.
18. Agustí, A.G.N., J. Roca, J.A. Barberà, J. Casademont, R. Rodriguez-Roisin, and P.D. Wagner. 1994. Effect of sampling site on femoral venous blood gas values. J. Appl. Physiol. 77:2018-2022.
19. 2 Transport to Tissue XII. J Piiper, T.K. Goldstick, and M. Meyer, editors. New York, Plenum Press. 825-833.
20. Bohr, C. 1909. Uber die spezitische Tatigkeit der Lungen bei der Respiratorischen Gasaufnahme und ihr Verhalten zu der durch die Alveolarwand stattfindenden Gasdiffusion. Scand. Arch. Physiol. 22:221-280.
21. 2max in normal humans. J. Appl. Physiol. 67:291-299.
22. Wagner, P.D. 1977. Diffusion and chemical reaction in pulmonary gas exchange. Physiol. Rev. 57:257-312.
23. Rosberg, B., and K. Wulff. 1979. Regional blood flow in normovolaemic and hypovolaemic haemodilution. Br. J. Anaesth. 51:423-430.
24. Fan, F.C.H., R.Y.Z. Chen, G.B. Schuessler, and S. Chien. 1980. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. Am J. Physiol. 238:H545-H552.
25. 31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients. J. Clin. Invest. 91:420-424.
26. Keller, M.W., D.N. Damon, and B.R. Duling. 1994. Determination of capillary tube hematocrit during arteriolar microperfusion. Ant. J. Physiol. 266: H2229-H2238.
27. Moore, G.E., B. Parsons, J. Stray-Gundersen, P.L. Painter, K.R. Brinker, and J.H. Mitchell. 1993. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J. Kidney Dis. 22:277-287.
28. 2 uptake in hypoxia. Respir. Physiol. 46:193-208.
29. 2 uptake in canine gastrocnemius muscle in situ. J. Appl. Physiol. 70:1105-1112.
30. Diesel, W., M. Emms, B.K. Knight, T.D. Noakes, R. van Zyl Smit, R.O.C. Kaschula, and C.C. Sinclair-Smith. 1993. Morphologic features of the myopathy associated with chronic renal failure. Am. J. Kidney Dis. 22:677-684.
31. Bradley, J.R., J.R. Anderson, D.B. Evans, and A.J. Cowley. 1990. Impaired nutritive skeletal muscle blood flow in patients with chronic renal failure. Clin. Sci. 79:239-245.
32. 2 in dog gastrocnemius in situ. J. Appl. Physiol. 74:1697-1703.
33. Wittenberg, B.A., and J.B. Wittenberg. 1993. Effects of carbon monoxide on isolated heart muscle cells. Res. Rep. Health Eff. Inst. 62:1-21.